Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Razoxane

🥰Excellent
Catalog No. T26046Cas No. 21416-67-1

Razoxane is used as an antimitotic agent with immunosuppressive properties.

Razoxane

Razoxane

🥰Excellent
Purity: 99.42%
Catalog No. T26046Cas No. 21416-67-1
Razoxane is used as an antimitotic agent with immunosuppressive properties.
Pack SizePriceAvailabilityQuantity
1 mg$100In Stock
5 mg$247In Stock
10 mg$363In Stock
25 mg$619In Stock
50 mg$818In Stock
100 mg$1,090In Stock
1 mL x 10 mM (in DMSO)$226In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Razoxane"

Select Batch
Purity:99.42%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Razoxane is used as an antimitotic agent with immunosuppressive properties.
In vivo
This tumor model is characterized by osteoid formation and spontaneous metastasization to lungs, kidneys and lymph nodes. Razoxane given intraperitoneally (i.p.) from 2 days before to 14 days after tumor transplantation (30 mg/kg or 10 mg/kg per day) resulted in a dose-dependent prolongation of median survival time (83 or 48 days respectively, versus 38 days for the control group), but showed no influence on the growth of the primary tumor. Early treatment with razoxane (30 mg/kg i.p. from day -2 to +14) showed a greater inhibition of pulmonary metastases than later treatment (30 mg/kg i.p. from day +14 to +28 after transplantation). Whereas 59.9 per cent of the total sectional area of the lungs in the control animals was covered by osteosarcoma metastases, only 3.4 per cent and 26.1 per cent respectively was affected in the early and late razoxane treatment groups. Toxic side-effects of these treatment schedules were reversible diffuse alopecia, but no retardation of body weight gain[2].
Chemical Properties
Molecular Weight268.27
FormulaC11H16N4O4
Cas No.21416-67-1
SmilesCC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1
Relative Density.1.2576 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/ml (223.66 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7276 mL18.6379 mL37.2759 mL186.3794 mL
5 mM0.7455 mL3.7276 mL7.4552 mL37.2759 mL
10 mM0.3728 mL1.8638 mL3.7276 mL18.6379 mL
20 mM0.1864 mL0.9319 mL1.8638 mL9.3190 mL
50 mM0.0746 mL0.3728 mL0.7455 mL3.7276 mL
100 mM0.0373 mL0.1864 mL0.3728 mL1.8638 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Razoxane | purchase Razoxane | Razoxane cost | order Razoxane | Razoxane chemical structure | Razoxane in vivo | Razoxane formula | Razoxane molecular weight